Abstract
The human defensins are a group of cationic antimicrobial peptides that range in size from 2 to 5 kDa and share a common structural motif of six disulphide-linked cysteines. Several naturally occurring human α- and β-defensins have been identified over the past two decades. They have a wide variety of antimicrobial effects, and their potential to avoid the development of resistance to antimicrobial treatment makes them attractive as therapeutic agents. Human defensins have recently been the focus of medical and molecular biology studies due to their promising application in medicine and the pharmaceutical industry. This work aims to provide a comprehensive summary of the current developments of human defensins, including their identification, categorization, molecular features, expression, modes of action, and potential application in medical settings. Current obstacles and future opportunities for using human defensins are also covered. Furthermore, we shed light on the potential of this class as an antiviral agent, particularly against SARS CoV-2, by providing an in silico-based investigation of their plausible mechanisms of action.
| Original language | English |
|---|---|
| Pages (from-to) | 1563-1583 |
| Number of pages | 21 |
| Journal | Probiotics and Antimicrobial Proteins |
| Volume | 17 |
| Issue number | 3 |
| Early online date | 18 Dec 2024 |
| DOIs | |
| Publication status | Published - 30 Jun 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- human defensins
- antimicrobial peptides
- SARS CoV-2
- in silico analysis
Fingerprint
Dive into the research topics of 'Human defensins: structure, function, and potential as therapeutic antimicrobial agents with highlights against SARS CoV-2'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver